BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28990973)

  • 1. The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate.
    Di Gregorio E; Ferrauto G; Furlan C; Lanzardo S; Nuzzi R; Gianolio E; Aime S
    Invest Radiol; 2018 Mar; 53(3):167-172. PubMed ID: 28990973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd accumulation in tissues of healthy mice upon repeated administrations of Gadodiamide and Gadoteridol.
    Di Gregorio E; Iani R; Ferrauto G; Nuzzi R; Aime S; Gianolio E
    J Trace Elem Med Biol; 2018 Jul; 48():239-245. PubMed ID: 29773187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
    Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
    Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents.
    Erdene K; Nakajima T; Kameo S; Khairinisa MA; Lamid-Ochir O; Tumenjargal A; Koibuchi N; Koyama H; Tsushima Y
    Jpn J Radiol; 2017 Oct; 35(10):568-573. PubMed ID: 28730467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF.
    Wang S; Hesse B; Roman M; Stier D; Castillo-Michel H; Cotte M; Suuronen JP; Lagrange A; Radbruch H; Paul F; Taupitz M; Schellenberger E; Sack I; Infante-Duarte C
    Invest Radiol; 2019 Oct; 54(10):617-626. PubMed ID: 31033673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
    Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
    Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats.
    Boyken J; Frenzel T; Lohrke J; Jost G; Schütz G; Pietsch H
    Invest Radiol; 2019 Feb; 54(2):76-82. PubMed ID: 30358694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
    Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
    J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition patterns of iatrogenic lanthanum and gadolinium in the human body depend on delivered chemical binding forms.
    Bücker P; Richter H; Radbruch A; Sperling M; Brand M; Holling M; Van Marck V; Paulus W; Jeibmann A; Karst U
    J Trace Elem Med Biol; 2021 Jan; 63():126665. PubMed ID: 33152670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
    Krause W; Schuhmann-Giampieri G; Bauer M; Press WR; Muschick P
    Invest Radiol; 1996 Aug; 31(8):502-11. PubMed ID: 8854197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
    Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
    Br J Radiol; 2016 Oct; 89(1066):20160509. PubMed ID: 27459250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Impaired Renal Function on Gadolinium Retention After Administration of Gadolinium-Based Contrast Agents in a Mouse Model.
    Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
    Invest Radiol; 2016 Oct; 51(10):655-60. PubMed ID: 27299580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions.
    Boyken J; Frenzel T; Lohrke J; Jost G; Pietsch H
    Invest Radiol; 2018 May; 53(5):278-285. PubMed ID: 29319556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents.
    Delfino R; Biasotto M; Candido R; Altissimo M; Stebel M; Salomè M; van Elteren JT; Vogel Mikuš K; Zennaro C; Šala M; Addobbati R; Tromba G; Pascolo L
    Toxicol Lett; 2019 Feb; 301():157-167. PubMed ID: 30476537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
    Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
    Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model.
    Robert P; Fingerhut S; Factor C; Vives V; Letien J; Sperling M; Rasschaert M; Santus R; Ballet S; Idée JM; Corot C; Karst U
    Radiology; 2018 Aug; 288(2):424-433. PubMed ID: 29786486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.